press

Brosh Capital is seeking to replace the Alcobra board of directors with its own directors. Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) today published a document stating that the Brosh Capital fund,

LONDON (Alliance News) – Matomy Media Group Ltd on Friday said shareholders have supported its proposals to increase the size of the board and appoint two new directors, but the

Company Adds Two Directors to the Board Company to Continue Strategic Alternatives Process to Maximize Value for All Shareholders TEL AVIV, Israel, June 12, 2017 (GLOBE NEWSWIRE) — Alcobra Ltd.

“They would be happy if the owners would pay back the bonds. But in case they don’t, they know what to do.” Following successful investments in bonds from IDB, Matomy,

Kamada’s share price has plunged 40% in the past three months, following failure in a drug trial. Brosh Capital, led by portfolio manager and managing partner Amir Efrati, together with

Issues Open Letter to Chairman Outlining the Case for Change Expresses Concern with Alcobra’s Prolonged Underperformance, Capital Allocation, Board Oversight and Corporate Governance Nominates Six Highly Qualified Directors to Replace